Panaxea ICC is an unique combination anti-inflammatory compounds for chronic inflammatory diseases. ICC reduces various inflammatory mediators such as interleukin-6 (IL-6), IL-1 beta, TNF-alpha, prostaglandin E2 and leukotrienes.
Indications:
- Chronic Inflammation
- Rheumatoid & osteoarthritis
- Ulcerative colitis
- Crohn's disease
- Eczema
- SLE
- Cancer Protocols
- Lung cancer
- Breast Cancer
- Colorectal Cancer
- Inflammation induced angiogenesis
